Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

The value of progression-free survival to patients with advanced-stage cancer.

Fallowfield LJ, Fleissig A.

Nat Rev Clin Oncol. 2011 Oct 18;9(1):41-7. doi: 10.1038/nrclinonc.2011.156. Review.

PMID:
22009075
2.

Awareness of ovarian cancer risk factors, beliefs and attitudes towards screening: baseline survey of 21,715 women participating in the UK Collaborative Trial of Ovarian Cancer Screening.

Fallowfield L, Fleissig A, Barrett J, Menon U, Jacobs I, Kilkerr J, Farewell V; UKCTOCS Trialists.

Br J Cancer. 2010 Aug 10;103(4):454-61. doi: 10.1038/sj.bjc.6605809. Epub 2010 Jul 20.

3.

Multidisciplinary teams in cancer care: are they effective in the UK?

Fleissig A, Jenkins V, Catt S, Fallowfield L.

Lancet Oncol. 2006 Nov;7(11):935-43. Review.

PMID:
17081919
4.

Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial.

Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM, Yiangou C, Horgan K, Bundred N, Monypenny I, England D, Sibbering M, Abdullah TI, Barr L, Chetty U, Sinnett DH, Fleissig A, Clarke D, Ell PJ.

J Natl Cancer Inst. 2006 May 3;98(9):599-609. Erratum in: J Natl Cancer Inst. 2006 Jun 21;98(12):876.

PMID:
16670385
5.

Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer.

Fleissig A, Fallowfield LJ, Langridge CI, Johnson L, Newcombe RG, Dixon JM, Kissin M, Mansel RE.

Breast Cancer Res Treat. 2006 Feb;95(3):279-93. Epub 2005 Sep 15.

PMID:
16163445
6.

Let's ask them: a national survey of definitions of quality of life and its enhancement among people aged 65 and over.

Bowling A, Gabriel Z, Dykes J, Dowding LM, Evans O, Fleissig A, Banister D, Sutton S.

Int J Aging Hum Dev. 2003;56(4):269-306.

PMID:
14738211
8.

Tamoxifen for the prevention of breast cancer: psychosocial impact on women participating in two randomized controlled trials.

Fallowfield L, Fleissig A, Edwards R, West A, Powles TJ, Howell A, Cuzick J.

J Clin Oncol. 2001 Apr 1;19(7):1885-92.

PMID:
11283119
9.

Results of an intervention study to improve communication about randomised clinical trials of cancer therapy.

Fleissig A, Jenkins V, Fallowfield L.

Eur J Cancer. 2001 Feb;37(3):322-31.

PMID:
11239753
10.

Information needs of patients with cancer. Patients are frightened and their information needs fluctuate.

Fleissig A.

BMJ. 2000 Sep 9;321(7261):632; author reply 633. No abstract available.

11.

Patients need more than written prompts for communication to be successful.

Fleissig A, Glasser B, Lloyd M.

BMJ. 2000 Jan 29;320(7230):314-5. No abstract available.

12.

Achieving continuity of care and carer.

Fleissig A, Kroll D.

Mod Midwife. 1997 Aug;7(8):15-9.

PMID:
9348860
13.

General practitioners' views on the implementation of community-led maternity care in south Camden, London.

Fleissig A, Kroll D, McCarthy M.

Br J Gen Pract. 1997 Jan;47(414):45-6. Erratum in: Br J Gen Pract 1997 Feb;47(415):108.

15.
16.

Prevalence of procedures in childbirth.

Fleissig A.

BMJ. 1993 Feb 20;306(6876):494-5. No abstract available.

17.

Women's preference for place of birth.

Fleissig A, Cartwright A.

BMJ. 1992 Aug 22;305(6851):476. No abstract available.

18.
19.

"Transferable deaths": their epidemiological importance.

Fleissig A, Grant KA.

Br Med J (Clin Res Ed). 1984 Apr 14;288(6424):1123. No abstract available.

Supplemental Content

Loading ...
Support Center